Physician profile
Anne B Brown
NPI 1851331813
$1,540.31
in general payments reported to CMS, 2019-2025
24 companies · $82.60 in 2025
The $82.60 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $413 · 2021: $192 · 2022: $207 · 2023: $143 · 2024: $197 · 2025: $82.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $311.25 | 2019-2023 | Orilissa |
| Renovia INC | $216.93 | 2020 | |
| Therapeuticsmd, INC. | $173.46 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.78 | 2019-2025 | |
| Astellas Pharma US INC | $99.49 | 2019-2025 | Veozah |
| Organon LLC | $78.71 | 2022 | |
| Mayne Pharma Commercial LLC | $57.00 | 2023-2025 | |
| Hologic Sales and Service, LLC | $54.98 | 2021-2022 | |
| Avion Pharmaceuticals | $42.18 | 2019-2020 | |
| Coopersurgical, INC. | $41.14 | 2020-2023 | Paragard T 380a |
| Exact Sciences Corporation | $39.51 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $36.11 | 2020 | |
| Sumitomo Pharma America, INC. | $34.95 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $33.06 | 2024 | Ova1 |
| Roche Diagnostics Corporation | $31.89 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $29.44 | 2019 | |
| Daiichi Sankyo INC. | $25.47 | 2024 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $24.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $21.86 | 2019 | |
| Hologic INC | $19.62 | 2021 | |
| Sage Therapeutics, LLC | $16.70 | 2024 | |
| Agile Therapeutics, INC. | $16.13 | 2021 | |
| Pfizer INC. | $12.80 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.